or Try an Advanced Search...

    Antineoplastic Drugs Stocks List

    Symbol Grade Name % Change
    DCPH A Deciphera Pharmaceuticals, Inc. 0.04
    CNTX B Context Therapeutics Inc. -3.37
    SLS C SELLAS Life Sciences Group, Inc. 2.33
    SNDX C Syndax Pharmaceuticals, Inc. 3.02
    HRTX C Heron Therapeutics, Inc. 1.06
    IOVA C Iovance Biotherapeutics, Inc. 0.72
    STRO C Sutro Biopharma, Inc. 9.25
    BYSI C BeyondSpring, Inc. 11.40
    CLRB D Cellectar Biosciences, Inc. -1.20
    ORIC D Oric Pharmaceuticals, Inc. 2.56
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Cancer Clinical Medicine Cancer Treatment Medicine Biopharmaceutical Oncology Solid Tumors Chemotherapy Breast Cancer Occupational Safety And Health Blastoma Cancer Cell Cancer Therapeutics Cancer Therapies Endometrial Cancer Glioblastoma Immune System Immunotherapy National Cancer Institute Ovarian And Endometrial Cancers

    Related ETFs - A few ETFs which own one or more of the above listed Antineoplastic Drugs stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 5.72
    IDNA C iShares Genomics Immunology and Healthcare ETF 4.82
    JFWD D Jacob Funds Inc. Jacob Forward ETF 4.53
    BBP C BioShares Biotechnology Products Fund 3.17
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 2.92
    View all Antineoplastic Drugs ETFs...
    Compare ETFs
    Compare CNCR to BBP Compare CNCR to IDNA Compare IDNA to BBP

        Antineoplastic Drugs Stocks Recent News

        Date Stock Title
        May 7 HRTX Heron Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 7 HRTX Heron Therapeutics, Inc. (HRTX) Q1 2024 Earnings Call Transcript
        May 7 SNDX Syndax Pharmaceuticals Q1 2024 Earnings Preview
        May 7 HRTX Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Overview: Surpasses Revenue Estimates
        May 7 HRTX Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say
        May 7 HRTX Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
        May 7 HRTX Heron Therapeutics GAAP EPS of -$0.02, revenue of $34.67M
        May 7 HRTX Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
        May 7 CLRB Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024
        May 6 ORIC ORIC Pharmaceuticals GAAP EPS of -$0.37 beats by $0.07
        May 6 ORIC ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
        May 6 HRTX Heron Therapeutics Q1 2024 Earnings Preview
        May 6 IOVA Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
        May 6 IOVA Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
        May 5 DCPH Wall Street Breakfast: The Week Ahead
        May 3 BYSI BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
        May 3 DCPH The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
        May 2 DCPH Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
        May 2 HRTX Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline
        May 2 CNTX Context Therapeutics stock jumps on $100M private placement
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Cancer Clinical Medicine Cancer Treatment Medicine Biopharmaceutical Oncology Solid Tumors Chemotherapy Breast Cancer Occupational Safety And Health Blastoma Cancer Cell Cancer Therapeutics Cancer Therapies Endometrial Cancer Glioblastoma Immune System Immunotherapy National Cancer Institute Ovarian And Endometrial Cancers
        Antineoplastic Drugs

        Antineoplastic drugs, also known as cytotoxic drugs, are a type of medication used to treat cancer. They work by interfering with the growth and spread of cancer cells. These drugs can be used alone or in combination with other treatments, such as surgery, radiation therapy, or hormone therapy.

        Browse All Tags